Oxcarbazepine-induced Stevens-Johnson syndrome: a case report
- PMID: 19321411
- PMCID: PMC11917620
- DOI: 10.1016/S1607-551X(09)70045-2
Oxcarbazepine-induced Stevens-Johnson syndrome: a case report
Abstract
Although carbamazepine (CBZ) is the most common cause of Stevens-Johnson syndrome (SJS), a new anticonvulsant, oxcarbazepine, which is structurally related to carbamazepine, has been shown to induce SJS, although extremely rarely. Recently, a strong association was found between human leukocyte antigen (HLA) B*1502 and CBZ-induced SJS/TEN in a Han Chinese population. Here, we report a case with SJS, which was induced by oxcarbazepine. HLA genotyping in the patient showed HLA-B*1518/B*4001. HLA-B*1518 is a HLA-B15 variant. The genetic significance of HLA-B*1518 in association with oxcarbazepine-induced SJS needs to be further studied.
References
-
- Auquier‐Dunant A, Mockenhaupt M, Naldi L, et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens‐Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002; 138: 1019–1024. - PubMed
-
- Mockenhaupt M, Messenheimer J, Tennis P, et al. Risk of Stevens‐Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology. 2005; 64: 1134–1138. - PubMed
-
- Medical Economics . Physician's desk reference. 55th edition. Montvale, NJ: Thomson PDR. 2001.
-
- Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens‐Johnson syndrome. Nature. 2004; 428: 486. - PubMed
-
- Frisch PO, Ruiz‐Maldonado R. Erythema multiforme, Stevens‐Johnson syndrome and toxic epidermal necrosis. In Freedberg IM, Eisen AZ, Wolff K, et al., eds. Fitzpatrick's Dermatology in General Medicine. 6th edition. New York: McGraw‐Hill. 2003, 543–557.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
